LECTURE 7: Comprehensive Study Notes on Receptors, Cell Signaling, and Glycogen Breakdown

Overview of Plasma Membrane Receptors and Signal Transduction

• Cellular survival and systemic coordination require functional plasma membranes capable of membrane transport (e.g., moving nutrients such as glucose across the bilayer), enzymatic activity, and cell-to-cell communication.

• Intercellular communication relies on signaling cells releasing chemical messengers (such as neurotransmitters or hormones) that bind specifically to surface receptors on target cells to induce intracellular responses.

• Target cells receive extracellular signals via specialized plasma membrane receptors, transducing extracellular binding events into specific intracellular functional changes.

Classifications of Plasma Membrane Receptors

• Ion Channel-Coupled Receptors (Ligand-Gated Ion Channels):

  • Function by converting chemical signals directly into electrical or ionic signals.

  • Upon extracellular ligand binding, the receptor undergoes a conformational change that opens an aqueous pore through the plasma membrane, allowing specific ions to flow down their electrochemical gradient.

  • When the ligand dissociates, the channel returns to a closed conformation, halting ion flux.

• Enzyme-Coupled Receptors:

  • Transmembrane proteins that either possess intrinsic enzymatic activity within their intracellular domains or directly associate with an intracellular enzyme.

  • Intrinsic Catalytic Domains: Signal molecules (often dimeric in structure) bind extracellularly, causing receptor dimerization or structural rearrangement that activates the internal catalytic domains.

  • Associated Enzymes: Binding of a monomeric signal molecule induces a conformational shift that recruits and activates an independent cytosolic or membrane-associated enzyme.

• G Protein-Coupled Receptors (GPCRs):

  • Represent the largest superfamily of cell-surface receptors, with approximately $800$ distinct GPCR genes identified in the human genome.

  • Characterized structurally by seven transmembrane \text{̣}\text{̣}\boldsymbol{\bar{\beta}}-helical domains spanning the phospholipid bilayer.

  • GPCRs regulate intracellular processes primarily by controlling the cytosolic concentration of small signaling molecules known as second messengers.

General Framework of Second Messenger Systems

• Definition and Properties of Second Messengers:

  • Small, low-molecular-weight molecules or ions.

  • Predominantly hydrophilic, allowing them to dissolve and diffuse rapidly through the aqueous cytosol.

  • Function as allosteric regulators by binding to non-catalytic site regions of target proteins, altering protein conformation, and modulating enzymatic or structural activity.

• Conformational Modulation Example ($\text{Ca}^{2+}$ Signaling):

  • Free intracellular Calcium ($\text{Ca}^{2+}$) acts as a critical second messenger.

  • Binding of $\text{Ca}^{2+}$ to target proteins (such as calmodulin) induces a substantial conformational transition between the $\text{Ca}^{2+}$-free (apo) state and the $\text{Ca}^{2+}$-bound active state, exposing binding interfaces for effector regulation.

• General Transduction Linear Chain:   $\text{Ligand + Receptor} \rightarrow \text{Activates Transducer (T)} \rightarrow \text{Activates Effector Enzyme} \rightarrow \text{Generates Second Messenger} \rightarrow \text{Allosteric Modulation of Target Proteins} \rightarrow \text{Cellular Response}$

  • Transducer: Heterotrimeric G protein consisting of $\alpha$, $\beta$, and $\gamma$ subunits.

  • Effector: Membrane-bound or cytosolic enzyme (e.g., adenylyl cyclase) that synthesizes or mobilizes second messengers upon transducer activation.

Chemical Diversity and Targets of Second Messengers

• Second Messenger Specifics and Target Enzymes:

  • Cyclic Adenosine Monophosphate ($3',5'\text{-Cyclic AMP}$ / $\text{cAMP}$): Generated from $\text{ATP}$ by adenylyl cyclase; directly binds to and activates Protein Kinase A (PKA).

  • Cyclic Guanosine Monophosphate ($3',5'\text{-Cyclic GMP}$ / $\text{cGMP}$): Activates Protein Kinase G (PKG) and opens cation channels in vertebrate photoreceptor rod cells.

  • 1,2-Diacylglycerol ($\text{DAG}$): Lipophilic molecule retained in the membrane that activates Protein Kinase C (PKC).

  • Inositol 1,4,5-trisphosphate ($\text{IP}_3$): Hydrophilic sugar-phosphate that diffuses to the endoplasmic reticulum (ER) membrane to open ligand-gated $\text{Ca}^{2+}$ channels.

  • Calcium Ions ($\text{Ca}^{2+}$): Unique among major second messengers because it is an inorganic ion rather than an enzymatically synthesized organic molecule. Its intracellular levels are regulated via channel-mediated release or active transport pumps.

Structural and Metabolic Basis of Glycogen Storage

• Glycogen Molecular Architecture:

  • Serves as the primary storage polysaccharide for glucose in animal tissues, predominantly localized within liver hepatocytes and skeletal muscle cells.

  • Composed of glucose monomers linked linearly via \text{̣}\text{̣}\boldsymbol{\bar{\beta}}\text{ 1,4-glycosidic bonds} in the main polymer backbone.

  • Features frequent branch points created by \text{̣}\text{̣}\boldsymbol{\bar{\beta}}\text{ 1,6-glycosidic bonds}, yielding a highly branched, dense spherical granule.

• Cytoplasmic Granules:

  • In liver hepatocytes, glycogen accumulates in distinct cytoplasmic clusters or granules visible under electron microscopy at a scale around $1\,\mu\text{m}$.

• Enzymatic Reactions of Glycogen Metabolism:

  • Glycogen Synthesis: Catalyzed by Glycogen synthase, which attaches a activated glucose unit from Uridine Diphosphate Glucose (UDP-glucose) onto an existing polymer chain:     $\text{UDP-glucose} + \text{Glycogen}_{(n\text{ residues})} \rightarrow \text{UDP} + \text{Glycogen}_{(n+1\text{ residues})}$

  • Glycogen Breakdown (Glycogenolysis): Catalyzed by Glycogen phosphorylase, which uses inorganic phosphate ($\text{P}_i$) to cleave terminal glucose units off the non-reducing ends of glycogen:     $\text{Glycogen}_{(n+1\text{ residues})} + \text{P}_i \rightarrow \text{Glucose 1-phosphate} + \text{Glycogen}_{(n\text{ residues})}$

Endocrine Regulation of Blood Glucose: Glucagon Signaling

• Physiological Trigger (Hypoglycemia):

  • When blood glucose concentration drops below normal physiological thresholds, pancreatic $\alpha$ cells sense the deficiency and secrete the peptide hormone glucagon into the bloodstream.

• Endocrine Targeting:

  • Glucagon travels systemically through the circulation to target liver hepatocytes.

  • Binding of glucagon to its cell-surface receptor initiates an intracellular signal transduction cascade that stimulates glycogenolysis, generating free glucose that is transported out into the blood to restore normoglycemia.

The Molecular Phosphorylation Cascade and Switch Mechanisms

• Reversible Covalent Modification:

  • Protein phosphorylation and dephosphorylation function as a central molecular switch mechanism governing protein activity.

  • Protein Kinases: Enzymes that catalyze the transfer of a $\gamma$-phosphate group from $\text{ATP}$ to specific hydroxylated amino acid side chains (serine, threonine, or tyrosine) on target proteins:     $\text{Target Protein} + \text{ATP} \xrightarrow{\text{Kinase}} \text{Target Protein-PO}_4^{2-} + \text{ADP}$

  • Protein Phosphatases: Enzymes that hydrolytically remove phosphate groups from phosphorylated target proteins, returning them to their baseline state:     $\text{Target Protein-PO}_4^{2-} \xrightarrow{\text{Phosphatase}} \text{Target Protein} + \text{P}_i$

• Structural Regulation of Protein Kinase A (PKA):

  • In its inactive state, PKA exists as a heterotetrameric complex consisting of two Regulatory ($R$) subunits and two Catalytic ($C$) subunits ($R_2C_2$).

  • Each $R$ subunit contains two binding sites for $\text{cAMP}$.

  • Binding of four total $\text{cAMP}$ molecules to the $R_2C_2$ tetramer induces a conformational shift that dissociates the regulatory subunits, freeing the two active $C$ monomeric protein kinase domains.

Step-by-Step Summary of the Glucagon Signal Transduction Pathway

• Step 1: Hormone Binding (Reception)

  • Glucagon binds extracellularly to the Glucagon Receptor, a specific G protein-coupled receptor (GPCR) embedded in the liver cell plasma membrane.

• Step 2: Transducer Activation (G Protein Exchange)

  • Conformational shifts in the activated GPCR stimulate the associated heterotrimeric G protein ($G_s$).

  • The $G_{\alpha s}$ subunit releases bound Guanosine Diphosphate ($\text{GDP}$) and binds Guanosine Triphosphate ($\text{GTP}$).

  • $G_{\alpha s}\text{-GTP}$ dissociates from the $G_{\beta\gamma}$ subunit complex.

• Step 3: Effector Activation

  • $G_{\alpha s}\text{-GTP}$ functions as an allosteric activator for the membrane-bound effector enzyme Adenylyl Cyclase.

• Step 4: Second Messenger Generation

  • Active Adenylyl Cyclase catalyzes the conversion of cytosolic $\text{ATP}$ into cyclic $\text{AMP}$ ($\text{cAMP}$) and pyrophosphate ($\text{PP}_i$):     $\text{ATP} \xrightarrow{\text{Adenylyl Cyclase}} \text{cAMP} + \text{PP}_i$

• Step 5: Activation of Protein Kinase A (PKA)

  • Intracellular $\text{cAMP}$ concentration rises rapidly; $\text{cAMP}$ diffuses through the cytosol and binds allosterically to the regulatory ($R$) subunits of PKA.

  • Dissociation releases active catalytic ($C$) subunits of PKA.

• Step 6: Phosphorylation Cascade Activation

  • Active PKA transfers a phosphate group from $\text{ATP}$ onto Glycogen Phosphorylase Kinase, converting it from an inactive (OFF) state to an active (ON) state.

  • Active Glycogen Phosphorylase Kinase subsequently phosphorylates Glycogen Phosphorylase, converting it from an inactive (OFF) state to an active (ON) state.

• Step 7: Cellular Response (Glycogen Breakdown and Glucose Release)

  • Active Glycogen Phosphorylase cleaves terminal glucose residues from stored glycogen via phosphorolysis, producing Glucose 1-phosphate.

  • Glucose 1-phosphate is converted to free glucose and exported out of the hepatocyte through plasma membrane transporters into the bloodstream, elevating blood sugar levels back to homeostasis.